Comparing two types of pacemakers for heart failure patients
Part of Heart & circulation clinical trials.
This trial tests if a new pacemaker method (CSP) works better than the standard method (BiVP) for people with heart failure who already have a right ventricular pacemaker and need an upgrade.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have heart failure with a reduced ejection fraction (LVEF below 50%)
- You have had a right ventricular pacemaker for at least 3 months
- Your heart failure symptoms are moderate to severe (NYHA class II to IV)
- You have elevated NT-proBNP levels in your blood
- Your right ventricle is paced more than 40% of the time
- You are between 18 and 80 years old
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with a standard pacemaker that stimulates the right ventricle most of the time. It tests whether a newer type of pacemaker (CRT) can improve heart function and symptoms. If you have a weakened heart (LVEF between 35-50%) and your heart failure has gotten worse, this study may be a good fit.
This trial compares two types of pacemaker placement to improve heart function in people with heart failure. One method paces the heart's natural conduction system, while the other paces the lower chambers of the heart. The goal is to find which approach works better for heart resynchronization therapy.
This trial compares two types of “left-side” heart pacing to see which one works better in people with weak heart pumping. It may help guide the best pacing choice for improving heart function and symptoms.
This trial compares two types of heart pacing to see which improves outcomes for people with heart failure. It may help those who need pacing to better coordinate heartbeats and relieve symptoms.
This study compares two pacing methods to help your heart beat in sync. If you need a cardiac resynchronization therapy (CRT) device, this trial will see if a newer pacing method is just as good as the standard one.
This trial compares two ways to pace the heart in people with heart failure and a wide QRS (a sign the heart's electrical signals are slowed). The goal is to see which method better reduces the risks of death, heart failure hospitalization, or needing a heart transplant.
Hear when a new Conduction System Pacing trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.